Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 306
Filter
1.
Pathologica ; 111(1): 48-50, 2019 Mar.
Article in English | MEDLINE | ID: mdl-31217623

ABSTRACT

In the last 30 years a revolution has occurred in the diagnosis and management of vascular anomalies. The great changes began with Mulliken and Glowacki separation of hemangiomas and vascular anomalies. Their work has now morphed into the ISSVA classification. Subsequently the discovery of the significance of the presence of GLUT-1 in the diagnosis of the hemangiomas of infancy gave us a new marker in our quest for accurate classification. Now the genetic breakthroughs have led us into a "Star Wars" like environment in the experimental laboratory. During all these events the critical role of the pathologist has become more evident. Understanding the histopathology of anomalies has greatly aided in our approach to therapies. Moreover, genetic findings do not have full significance without the morphologic framework.


Subject(s)
Clinical Laboratory Techniques , Vascular Malformations , Diagnosis, Differential , Hemangioma/pathology , Humans , Vascular Malformations/diagnosis , Vascular Malformations/pathology
2.
Dermatol Online J ; 24(10)2018 10 15.
Article in English | MEDLINE | ID: mdl-30677812

ABSTRACT

Cutaneous mucinosis of infancy (CMI) is a rare dermatologic condition, first reported in 1980 and currently classified within the complex group of papular mucinoses. We report a case of CMI and review the prior 13 cases in the literature. The patient was a 5-year-old girl who presented with asymptomatic dermal papules and plaques on her leg and back with no overlying color change. These lesions were first noticed during infancy and had become slightly more evident over time. The patient had a history of birthmarks and eczema. Her family history included eczema, allergies, photosensitivity, and Graves disease. Pre-biopsy clinical differential diagnosis included connective tissue nevus, granuloma annulare, myofibroma, lipofibroma, and lymphangioma. Biopsies revealed significant increase in interstitial mucin within the reticular and mid dermis, without significant sclerosis or fibroblastic proliferation. The relatively quiescent pattern of interstitial mucinosis with slight fibrocyte hyperplasia presenting as dermal papules-plaques on the trunk and extremities was most consistent with a diagnosis of CMI. We report another case of CMI in an otherwise healthy patient. Our patient is unique as she is the first CMI patient with a family history of Graves disease, although our patient appeared euthyroid. We will also review the literature on this rare entity.


Subject(s)
Scleromyxedema/pathology , Biopsy , Child, Preschool , Diagnosis, Differential , Female , Granuloma Annulare/diagnosis , Graves Disease , Humans , Medical History Taking , Mucinoses/diagnosis , Mucinoses/pathology , Myofibroma/diagnosis , Nevus/diagnosis , Scleromyxedema/diagnosis , Skin Neoplasms/diagnosis
3.
Br J Dermatol ; 177(6): 1601-1611, 2017 12.
Article in English | MEDLINE | ID: mdl-28599054

ABSTRACT

BACKGROUND: Port-wine stain (PWS) is a vascular malformation characterized by progressive dilatation of postcapillary venules, but the molecular pathogenesis remains obscure. OBJECTIVES: To illustrate that PWS endothelial cells (ECs) present a unique molecular phenotype that leads to pathoanatomical PWS vasculatures. METHODS: Immunohistochemistry and transmission electron microscopy were used to characterize the ultrastructure and molecular phenotypes of PWS blood vessels. Primary culture of human dermal microvascular endothelial cells and in vitro tube formation assay were used for confirmative functional studies. RESULTS: Multiple clinicopathological features of PWS blood vessels during the development and progression of the disease were shown. There were no normal arterioles and venules observed phenotypically and morphologically in PWS skin; arterioles and venules both showed differentiation impairments, resulting in a reduction of arteriole-like vasculatures and defects in capillary loop formation in PWS lesions. PWS ECs showed stemness properties with expression of endothelial progenitor cell markers CD133 and CD166 in non-nodular lesions. They also expressed dual venous/arterial identities, Eph receptor B1 (EphB1) and ephrin B2 (EfnB2). Co-expression of EphB1 and EfnB2 in normal human dermal microvascular ECs led to the formation of PWS-like vasculatures in vitro, for example larger-diameter and thick-walled capillaries. CONCLUSIONS: PWS ECs are differentiation-impaired, late-stage endothelial progenitor cells with a specific phenotype of CD133+ /CD166+ /EphB1+ /EfnB2+ , which form immature venule-like pathoanatomical vasculatures. The disruption of normal EC-EC interactions by coexistence of EphB1 and EfnB2 contributes to progressive dilatation of PWS vasculatures.


Subject(s)
Dilatation, Pathologic/etiology , Endothelial Progenitor Cells/metabolism , Port-Wine Stain/pathology , Receptor, EphB1/metabolism , Receptor, EphB2/metabolism , Skin Diseases, Vascular/etiology , Adolescent , Adult , Arterioles/pathology , Cells, Cultured , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Port-Wine Stain/metabolism , Skin/blood supply , Skin Diseases, Vascular/pathology , Venules/pathology , Young Adult
5.
J Eur Acad Dermatol Venereol ; 31(3): 443-449, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27427400

ABSTRACT

BACKGROUND: Neuropeptide Y (NPY) is involved in the carcinogenesis of different tumours, especially neural crest-derived tumours. OBJECTIVE: The aim of our study is to investigate the expression of NPY on melanoma and its relation with prognostic histological parameters and survival. METHODS: This is a retrospective observational study of two independent series, with a total of 79 primary melanomas, diagnosed in two independent University Hospitals in Spain, from January 2000 to December 2004. RESULTS: We found a significant higher expression of NPY on superficial spreading melanoma and lentigo maligna (40%) (P = 0.030). Thinner tumours were associated with higher NPY expression (Clark level, P = 0.003; Breslow level, P = 0.012). Melanomas with low NPY expression were associated with intense cell proliferation (Ki-67, P = 0.034), high density of peritumoral mast cell infiltrates (P = 0.033) and low E-cadherin expression (P = 0.031). Melanomas with high NPY expression exhibited significant differences in terms of relapse time (median: 114 vs. 68 months, P = 0.008) and overall survival (114 vs. 74 months, P = 0.004). CONCLUSION: High expression of NPY was associated with better prognostic histological parameters, low peritumoral mast cells density, presence of adhesion proteins and better outcome.


Subject(s)
Melanoma/chemistry , Neuropeptide Y/analysis , Skin Neoplasms/chemistry , Adult , Aged , Aged, 80 and over , Cadherins/analysis , Cell Proliferation , Disease-Free Survival , Female , Humans , Hutchinson's Melanotic Freckle/chemistry , Hutchinson's Melanotic Freckle/pathology , Ki-67 Antigen/analysis , Male , Mast Cells , Melanoma/pathology , Middle Aged , Retrospective Studies , Skin Neoplasms/pathology , Survival Rate , Tumor Burden
6.
Hernia ; 21(3): 489-492, 2017 06.
Article in English | MEDLINE | ID: mdl-26693715

ABSTRACT

INTRODUCTION: Delayed type IV hypersensitivity reactions are well established in the surgical setting with respect to external exposure via topical antibiotics and internal exposure via synthetic materials. In contrast, biologic matrix is derived from decellularized human or animal tissues and is consequently believed to elicit a minimal host inflammatory response. OBJECTIVE: We report a case of delayed type IV hypersensitivity reaction secondary to a biologic comprised of porcine-derived acellular dermal matrix, [Strattice™]. CONCLUSIONS: While biologic matrix is often preferred over synthetic mesh due to its decreased risk for infection, this case emphasizes that potential for hypersensitivity to the material persists. Type IV hypersensitivity reactions should be included in the differential diagnosis for suspected post-operative infections.


Subject(s)
Acellular Dermis/adverse effects , Hypersensitivity, Delayed/diagnosis , Prostheses and Implants/adverse effects , Surgical Wound Infection/diagnosis , Animals , Debridement , Device Removal , Diagnosis, Differential , Diagnostic Errors , Female , Humans , Hypersensitivity, Delayed/etiology , Retrospective Studies , Surgical Wound Infection/etiology , Swine
7.
Br J Dermatol ; 172(3): 669-76, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25283693

ABSTRACT

BACKGROUND: The recurrence of port-wine stain (PWS) blood vessels by pulsed dye laser (PDL)-induced angiogenesis is a critical barrier that must be overcome to achieve a better therapeutic outcome. OBJECTIVES: To determine whether PDL-induced angiogenesis can be suppressed by topical axitinib. METHODS: The mRNA expression profiles of 86 angiogenic genes and phosphorylation levels of extracellular signal regulated kinases (ERKs), phosphorylated protein kinase B (AKT) and ribosomal protein S6 kinase (p70S6K) in rodent skin were examined with or without topical axitinib administration after PDL exposure. RESULTS: The PDL-induced increased transcriptional levels of angiogenic genes peaked at days 3-7 post-PDL exposure. Topical application of 0·5% axitinib effectively suppressed the PDL-induced increase in mRNA levels of the examined angiogenic genes and activation of AKT, P70S6K and ERK from days 1 to 7 post-PDL exposure. After topical administration, axitinib penetrated into rodent skin to an approximate depth of 929·5 µm. CONCLUSIONS: Topical application of 0·5% axitinib can systematically suppress the PDL-induced early stages of angiogenesis via inhibition of the AKT/mammalian target of rapamycin/p70S6K and Src homology 2 domain containing transforming protein-1/mitogen-activated protein kinase kinase/ERK pathway cascades.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Lasers, Dye/adverse effects , Neovascularization, Pathologic/prevention & control , Protein Kinase Inhibitors/pharmacology , Administration, Cutaneous , Animals , Axitinib , Combined Modality Therapy , Extracellular Signal-Regulated MAP Kinases/metabolism , Imidazoles/administration & dosage , Imidazoles/pharmacology , Indazoles/administration & dosage , Indazoles/pharmacology , MAP Kinase Signaling System/radiation effects , Male , Port-Wine Stain/surgery , Protein Kinase Inhibitors/administration & dosage , Proto-Oncogene Proteins c-akt/metabolism , RNA, Messenger/metabolism , Rats, Sprague-Dawley , Recurrence , Ribosomal Protein S6 Kinases/metabolism
9.
Dermatology ; 227(1): 21-5, 2013.
Article in English | MEDLINE | ID: mdl-23860244

ABSTRACT

Large or giant cellular blue nevi are usually congenital and represent a challenge for the physician. Close anatomic structures may be altered by the size of the moles. In this article, we report the case of an uncommon large, agminated, cellular blue nevus of the 'plaque type' in a 42-year-old female. Due to the risks of malignant melanoma development on a large or giant blue nevus, we highlight the importance of proper histopathological diagnosis. Furthermore, because of the possibility that the nevus may invade the bone and cerebral tissues, we discuss the indication of a radiological diagnosis. The accurate correlation to clinical and histopathological findings and appropriate multidisciplinary management can save the lives of patients.


Subject(s)
Ear Neoplasms/pathology , Nevus, Blue/pathology , Skin Neoplasms/pathology , Adult , Ear Neoplasms/surgery , Female , Humans , Magnetic Resonance Imaging , Nevus, Blue/surgery , Skin Neoplasms/surgery
10.
Pathologica ; 101(5): 169-74, 2009 Oct.
Article in English | MEDLINE | ID: mdl-20218056

ABSTRACT

OBJECTIVE: Misdiagnosis of melanocytic lesions can result in unnecessary psychological distress to patients, under- or overtreatment, inaccurate prognosis and improper follow-up and family member surveillance. It is well recognized that, despite many attempts to 1) put forth a set of histologic criteria that can accurately and reproducibly be used to diagnose melanocytic lesions, and 2) identify reliable markers of malignancy as an adjunct to routine histopathology, misdiagnoses still occur in a significant number of cases. METHOD: A multi-color FISH probe mixture has been devised to assist pathologists in differential diagnosis of difficult melanocytic lesions. The mixture includes a centromeric probe for chromosome 6 and unique sequence probes for three other chromosomal regions that have most frequently shown amplifications or deletions in melanoma. We have carried out a preliminary evaluation of this new probe set in 25 cases of benign and malignant pigmented lesions. RESULTS: The tool reliably identified all nevi and ordinary melanomas, and only failed to identify a pigmented epithelioid melanocytoma and two malignant lesions that, by morphology and behavior, have distinct features from common invasive melanomas, i.e., a desmoplastic melanoma and a nevoid melanoma. Considering this, 100% specificity and 75% sensitivity was achieved. CONCLUSION: The FISH tool used in this study was able to separate accurately benign nevi from ordinary melanoma. Failure to identify uncommon melanocytic lesions adds to its advantage and calls for further studies to unveil the molecular profile of these rare entities.


Subject(s)
Melanoma/diagnosis , Nevus, Pigmented/diagnosis , Skin Neoplasms/diagnosis , Adolescent , Adult , Aged , Child , Diagnosis, Differential , Female , Humans , In Situ Hybridization, Fluorescence , Infant , Male , Melanoma/genetics , Middle Aged , Nevus, Pigmented/genetics , Sensitivity and Specificity , Skin Neoplasms/genetics
11.
Skin Pharmacol Physiol ; 20(6): 283-91, 2007.
Article in English | MEDLINE | ID: mdl-17717424

ABSTRACT

Lutein and zeaxanthin are xanthophyll carotenoids with potent antioxidant properties protecting the skin from acute photodamage. This study extended the investigation to chronic photodamage and photocarcinogenesis. Mice received either a lutein/zeaxanthin-supplemented diet or a standard nonsupplemented diet. Dorsal skin of female Skh-1 hairless mice was exposed to UVB radiation with a cumulative dose of 16,000 mJ/cm(2) for photoaging and 30,200 mJ/cm(2) for photocarcinogenesis. Clinical evaluations were performed weekly, and the animals were sacrificed 24 h after the last UVB exposure. For photoaging experiments, skin fold thickness, suprapapillary plate thickness, mast cell counts and dermal desmosine content were evaluated. For photocarcinogenesis, samples of tumors larger than 2 mm were analyzed for histological characterization, hyperproliferation index, tumor multiplicity, total tumor volume and tumor-free survival time. Results of the photoaging experiment revealed that skin fold thickness and number of infiltrating mast cells following UVB irradiation were significantly less in lutein/zeaxanthin-treated mice when compared to irradiated animals fed the standard diet. The results of the photocarcinogenesis experiment were increased tumor-free survival time, reduced tumor multiplicity and total tumor volume in lutein/zeaxanthin-treated mice in comparison with control irradiated animals fed the standard diet. These data demonstrate that dietary lutein/zeaxanthin supplementation protects the skin against UVB-induced photoaging and photocarcinogenesis.


Subject(s)
Lutein/administration & dosage , Skin Aging/drug effects , Skin Neoplasms/prevention & control , Ultraviolet Rays/adverse effects , Xanthophylls/administration & dosage , Animals , Desmosine/metabolism , Diet , Mast Cells/drug effects , Mast Cells/immunology , Mast Cells/radiation effects , Mice , Mice, Hairless , Skin/drug effects , Skin/pathology , Skin/physiopathology , Skin/radiation effects , Skin Aging/immunology , Skin Aging/pathology , Skin Neoplasms/etiology , Skin Neoplasms/pathology , Tumor Burden/drug effects , Zeaxanthins
13.
Histopathology ; 45(5): 433-51, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15500647

ABSTRACT

Dermal dendritic melanocytic proliferations are a broad group of congenital and acquired melanocytic lesions characterized by the presence of dermal spindled and dendritic cells resembling melanocytes migrating from the neural crest to the epidermis. Historically, they were subdivided into dermal melanocytoses (naevus of Ota, Ito, Mongolian spot and related conditions), blue naevi and malignant blue naevi. The purpose of this review is to provide an update on recent developments in the field with emphasis on new entities and their differential diagnosis.


Subject(s)
Cell Division , Melanocytes/pathology , Nevus, Blue/pathology , Skin Neoplasms/pathology , Animals , Horses , Humans , Melanocytes/cytology
14.
An Sist Sanit Navar ; 27 Suppl 1: 103-15, 2004.
Article in Spanish | MEDLINE | ID: mdl-15148516

ABSTRACT

The use of the indications of the laser in treating vascular malformations and infantile haemangiomas is based on the theory of selective photothermolysis, in which the oxyhaemoglobin is the target chromophore on which the light of the laser acts, thus avoiding damage to neighbouring tissues. The pulsed dye laser is the most employed and at present is the treatment of choice in capillary malformations (port-wine stains). A variable response is obtained, with a substantial clearing of the colour of the lesion after several sessions. Application at early ages seems to improve the results. Venous malformations, especially those localised in the mucosa, respond better to the Nd:YAG laser; lymphatic malformations to the CO2 laser. Arteriovenous malformations rarely respond. Use of the pulsed dye laser in the phase of proliferation of the haemangiomas is subject to controversy, except where there is ulceration. A rapid re-epithelialization is obtained in these cases following its use. In the involution phase, patients with residual vascular lesions can benefit from other lasers such as KTP or Nd:YAG. If they show an atrophic surface and scars these complications improve with the CO2 laser or Er:YAG. New treatment modalities are emerging, such as photodynamic therapy, whose efficacy and safety, both in the treatment of haemangiomas and vascular malformations, have yet to be confirmed.


Subject(s)
Blood Vessels/abnormalities , Hemangioma/radiotherapy , Laser Therapy , Blood Vessels/radiation effects , Child , Humans , Lymph Nodes/abnormalities , Lymph Nodes/radiation effects
15.
An. sist. sanit. Navar ; 27(supl.1): 103-115, ene. 2004. ilus
Article in Es | IBECS | ID: ibc-32323

ABSTRACT

El uso de las indicaciones del láser en el manejo de las malformaciones vasculares y los hemangiomas infantiles se fundamenta en la teoría de la fototermolisis selectiva, siendo la oxihemoglobina el cromóforo diana sobre el cual actúa la luz del láser, evitándose así el daño a tejidos vecinos. El láser de colorante pulsado es el más utilizado y es, actualmente, el tratamiento de elección en las malformaciones capilares (mancha en vino de Oporto). La respuesta obtenida es variable, alcanzándose un aclaramiento sustancial del color de la lesión, tras varias sesiones. La aplicación en edades tempranas parece mejorar los resultados. Las malformaciones venosas, especialmente las localizadas en la mucosa, responden mejor al láser de Nd:YAG; las malformaciones linfáticas al láser de CO2. Las malformaciones arteriovenosas raramente responden. El uso del láser de colorante pulsado en la fase proliferativa de los hemangiomas es controvertido, excepto si existe ulceración. En estos casos se obtiene una reepitelización rápida tras su empleo. En la fase involutiva, los pacientes con lesiones residuales vasculares pueden beneficiarse de otros láseres como KTP o Nd:YAG. Si presentan superficie atrófica y cicatrices mejoran con láser de CO2 o Er:YAG. Están emergiendo nuevas modalidades como la terapia fotodinámica cuya eficacia y seguridad, tanto en el tratamiento de los hemangiomas como de las malformaciones vasculares, está aún por confirmar (AU)


Subject(s)
Child , Humans , Lasers/therapeutic use , Hemangioma/therapy , Peripheral Vascular Diseases/therapy , Peripheral Vascular Diseases/congenital
16.
Br J Plast Surg ; 56(1): 44-6, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12706150

ABSTRACT

Malignant blue naevus (MBN) is a rare cutaneous tumour with a close biological resemblance to malignant melanoma. MBN spreads to regional lymph nodes, creating a dilemma in managing patients with clinically negative nodal basins. Sentinel lymph node (SLN) biopsy has evolved as a powerful staging tool by identifying occult metastatic nodal disease in patients with cutaneous malignancies. Here, we report a patient with MBN of the occipital scalp who underwent wide local excision together with preoperative lymphoscintigraphy and intraoperative radiolymphoscintigraphy and vital dye injection to identify all draining SLNs. No occult nodal disease was identified. This report adds to the growing body of literature supporting the role of SLN biopsy in staging individuals with cutaneous malignancies, including MBN.


Subject(s)
Head and Neck Neoplasms/surgery , Lymph Node Excision/methods , Nevus, Blue/surgery , Scalp , Skin Neoplasms/surgery , Adult , Female , Head and Neck Neoplasms/diagnostic imaging , Humans , Lymphatic Metastasis , Nevus, Blue/diagnostic imaging , Preoperative Care , Radionuclide Imaging , Sentinel Lymph Node Biopsy/methods , Skin Neoplasms/diagnostic imaging
18.
Arch Dermatol ; 137(12): 1607-20, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11735711

ABSTRACT

BACKGROUND: Infantile hemangiomas are common tumors, distinctive for their perinatal presentation, rapid growth during the first year of life, and subsequent involution-and for their expression of a unique immunophenotype shared by placental microvessels. Occasional "hemangiomas" differ from the classic form in presenting fully formed at birth, then following a static or rapidly involuting course. These congenitally fully developed lesions have generally been assumed to be clinical variants of more typical, postnatally developing hemangiomas. This assumption has not been tested by rigorous histologic and immunophenotypic comparisons. OBJECTIVE: To compare the histologic and immunohistochemical features of congenital nonprogressive hemangiomas with those of typical, postnatally proliferating, hemangiomas. DESIGN: All cellular vascular tumors resected from infants younger than 4 months at Arkansas Children's Hospital, Little Rock, over the past 20 years (43 lesions from 36 patients) were first characterized histologically and immunohistochemically, then clinically by chart review. SETTING: A university-affiliated pediatric hospital. MAIN OUTCOME MEASURES: Histologic appearance, immunoreactivity for the infantile hemangioma-associated antigens GLUT1 and LeY, and clinical behavior. RESULTS: Congenital nonprogressive hemangiomas differed from postnatally proliferating infantile hemangiomas in histologic appearance and immunohistochemical profile. Distinguishing pathologic features of these tumors were lobules of capillaries set within densely fibrotic stroma containing hemosiderin deposits; focal lobular thrombosis and sclerosis; frequent association with multiple thin-walled vessels; absence of "intermingling" of the neovasculature with normal tissue elements; and lack of immunoreactivity for GLUT1 and LeY. CONCLUSION: Congenital nonprogressive hemangiomas are histologically and immunophenotypically distinct from classically presenting hemangiomas of infancy, unlikely to be related to the latter in pathogenesis.


Subject(s)
Hemangioma/congenital , Hemangioma/pathology , Skin Neoplasms/congenital , Skin Neoplasms/pathology , Female , Glucose Transporter Type 1 , Hemangioma/classification , Humans , Immunohistochemistry , Infant , Infant, Newborn , Lewis Blood Group Antigens/immunology , Male , Medical Records , Monosaccharide Transport Proteins/immunology , Retrospective Studies , Skin Neoplasms/classification
19.
Arch Pathol Lab Med ; 125(10): 1295-306, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11570904

ABSTRACT

CONTEXT: The rapidly developing fields of melanoma research are revolutionizing the current concepts on melanoma etiology and pathogenesis and are introducing newer diagnostic techniques and potential therapeutic approaches. OBJECTIVES: To present the most current concepts on the etiology and pathogenesis of melanoma and to introduce the recent diagnostic techniques and the potential therapeutic approaches. METHODS: Data sources were reports on melanoma published in the English language literature and observations made using specimens available at Harvard University, Johns Hopkins Medical Center, Albany Medical College, Loyola University Medical Center, and University of Tennessee Health Science Center. RESULTS: Studies on melanoma containing chromosomal or genetic evaluation were selected for further analysis. Current clinical and pathologic categories with the reported genetic abnormalities were related to the latest information on pigment biology. The data extracted were used to develop a conceptual framework on the pathogenesis of melanoma; the generated model was then evaluated and used to suggest potential therapeutic approaches. CONCLUSIONS: (1) Melanoma is not genetically homogeneous, and the existing differences between the pathologic categories, particularly in areas such as type of growth phase (radial vs vertical growth), total vertical dimension, ulceration of primary tumor, and metastatic process, have profound prognostic and therapeutic implications. (2) Chromosomal aberrations and gene mutations are found in sporadic and familial melanomas; among the most important are those affecting the 9p21, which contains the p16 locus, a site known to be critical for normal progression of the cell cycle. Aberrant p16 expression is associated with more aggressive behavior. (3) Melanoma cells possess a remarkable repertoire of biosynthetic capacities represented by the production of hormones, growth factors, and their receptors that may sustain and accelerate tumor development and progression. For example, expression of the tumoral products alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone is regulated in vitro by ultraviolet light, a known carcinogen. (4) Melanomas differ from other tumors in their intrinsic capability to express melanogenic enzymes with the corresponding structural proteins to actually synthesize melanin. Melanogenesis-related proteins are rapidly entering the clinical arena, being used not only as diagnostic markers, but also as potential targets for melanoma therapy.


Subject(s)
Melanoma , Chromosome Aberrations , Chromosome Disorders , Disease Susceptibility , Female , Genetic Predisposition to Disease , Growth Substances/physiology , Humans , Immunotherapy , Male , Melanins/biosynthesis , Melanoma/diagnosis , Melanoma/etiology , Melanoma/pathology , Melanoma/therapy , Neoplasm Metastasis
20.
Arch Dermatol ; 137(5): 559-70, 2001 May.
Article in English | MEDLINE | ID: mdl-11346333

ABSTRACT

BACKGROUND: Juvenile hemangiomas are common, benign tumors, distinctive for their perinatal presentation, rapid growth during the first year of life, and subsequent involution. We recently reported that endothelia of hemangiomas highly express GLUT1, a glucose transporter normally restricted to endothelia with blood-tissue barrier function, as in brain and placenta. OBJECTIVE: To investigate possible further similarities between hemangioma and placental vessels. DESIGN: In a retrospective study of a variety of vascular tumors and anomalies, we assessed lesional immunoreactivities for the placenta-associated vascular antigens FcgammaRII, Lewis Y antigen (LeY), merosin, and GLUT1. SETTING: A university-affiliated pediatric hospital. MAIN OUTCOME MEASURE: Immunoreactivities scored for each antigen were summarized according to lesional type, compared with those of normal skin, brain, and placenta, and correlated with patient age, sex, and lesional location. RESULTS: All of 66 hemangiomas (patients aged 22 days to 7 years) showed intense immunoreactivity for FcgammaRII, merosin, LeY, and GLUT1. No immunoreactivities for these markers were seen in any of 26 vascular malformations, 4 granulation tissue specimens, 13 pyogenic granulomas, or in the tumor vasculature of 6 malignant tumors of nonvascular origin. Microvascular immunoreactivity for all 4 markers was observed in placental chorionic villi, but was absent in microvessels of normal skin and subcutis. Brain microvessels expressed only GLUT1 and merosin. CONCLUSIONS: A distinct constellation of tissue-specific markers is uniquely coexpressed by hemangiomas and placental microvessels. These findings imply a unique relationship between hemangioma and the placenta and suggest new hypotheses concerning the origin of these tumors.


Subject(s)
Hemangioma/blood supply , Microcirculation/physiology , Placenta/blood supply , Blood Vessels/abnormalities , Blood Vessels/metabolism , Cerebrovascular Circulation , Child , Child, Preschool , Chorionic Villi/blood supply , Female , Glucose Transporter Type 1 , Hemangioma/metabolism , Humans , Immunohistochemistry , Infant , Infant, Newborn , Laminin/metabolism , Lewis Blood Group Antigens/metabolism , Monosaccharide Transport Proteins/metabolism , Phenotype , Placenta/metabolism , Pregnancy , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...